Target intelligence / Profile preview

Multiple immune and stromal cell types via paracrine factors and surface adhesion molecules

Molecular classification
Other
01

Overview

The phrase "Multiple immune and stromal cell types via paracrine factors and surface adhesion molecules" does not refer to a single molecular target but rather describes the complex interaction network within the tumor microenvironment (TME) or a regenerative tissue niche. This system involves a diverse array of cells, including T lymphocytes, macrophages, dendritic cells, fibroblasts, and endothelial cells, which coordinate biological processes through secreted paracrine signals (e.g., cytokines, chemokines) and direct cell-to-cell adhesion (e.g., integrins, selectins). In pathological states like cancer, this network is often hijacked to create an immunosuppressive environment that protects malignant cells from immune surveillance and promotes metastasis. Therapeutic interventions targeting this system, such as mesenchymal stromal cell (MSC) therapies or multi-target checkpoint inhibitors, aim to disrupt these suppressive interactions and restore homeostatic or anti-tumor immune responses. Because it encompasses a broad range of cellular players and signaling pathways, it represents a systemic therapeutic focus rather than a discrete molecular entity.

Other names
Tumor microenvironmentTMEImmune-stromal nicheTissue microenvironmentCellular interaction network
02

Mechanism of action

Modulation of the cellular network through the secretion of cytokines and chemokines (paracrine factors) and direct cell-to-cell contact via adhesion molecules to alter the local immune landscape.

03

Biological functions

Immune responseCell adhesionSignal transductionAngiogenesisCell proliferationExtracellular matrix remodeling
04

Disease associations

CancerInflammationAutoimmune diseaseFibrosisGraft-versus-host disease
05

Safety considerations

Immune-related adverse events (irAEs)Cytokine release syndrome (CRS)Potential for pro-tumorigenic stromal remodelingOff-target systemic immunosuppression
06

Interacting drugs

Remestemcel-L

5 more in the full profile.

07

Biomarkers

Tumor-infiltrating lymphocytes (TILs)PD-L1 expressionFibroblast activation protein (FAP)Alpha-smooth muscle actin (alpha-SMA)Cytokine profiles (e.g., IL-6, TGF-beta, TNF-alpha)

Beyond the preview

Go deeper on Multiple immune and stromal cell types via paracrine factors and surface adhesion molecules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple immune and stromal cell types via paracrine factors and surface adhesion molecules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call